Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glimital-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Talent India

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimital-M2 Tablet PR

DiaBeta-Duo tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This dual-action formula helps regulate blood glucose. DiaBeta-Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, lightheadedness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. DiaBeta-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Primary Ingredients of Glimital-M2 Tablet PR

There is no text provided to rephrase. Please provide the text you wish to have rewritten.

Uses of Glimital-M2 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Glimital-M2 Tablet PR:

Follow your doctor's instructions or refer to the product label for usage guidance. Consume Glimital-M2 Tablet PR with a meal.

Common Side effects of Glimital-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimital-M2 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glimital-M2 Tablet PR with a meal.

How Glimital-M2 Tablet PR works:

Glimepiride and Metformin, the active components of Glimital-M2 Tablet PR, act synergistically to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, works through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimital-M2 Tablet PR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimital-M2 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Glimital-M2 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Glimital-M2 Tablet PR requires careful administration in individuals with impaired renal function. Dosage modification for Glimital-M2 Tablet PR might be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Glimital-M2 Tablet PR is contraindicated. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimital-M2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, Glimital-M2 Tablet PR is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimital-M2 Tablet PR :

Should you forget a Glimital-M2 Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimital-M2 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimital-M2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimital-M2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimital-M2 Tablet PR and seek immediate medical attention.
Glimital-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimital-M2 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimital-M2 Tablet PR use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimital-M2 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimital-M2 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimital-M2 Tablet PR
61
MRP 71
13% off